Bookmark?Remove?
AstraZeneca’s three-in-one inhaler helps COPD patients in trial
A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) – AstraZeneca said an inhaler for chronic obstructive pulmonary disease (COPD) delivered improved lung function in a late stage trial t... More »
